Patch0.6.3

Patch v0.6.3

Butterflies slow down to rein in Fairytale, Red Rose scales less at high stars, and the Goblin pack gets a round of buffs led by Heavy Bomb and Cannon.

Patch v0.6.3 🪵

Backpack Battles just added the Oaken Tower crossover: Time Pendant to their game!

Welcome to all new Oaklings!

I'm Bocary, the Solo dev of Oaken Tower. And I simply want to make Oaken Tower as great as possible! Join the Discord and chat if you have balance suggestions etc.

It would mean so much if you would consider leaving a Steam Review ❤️

Balance

The Fairytale nerf helped a ton, but it is still slightly too oppressive early game due to how easy it is to trigger with Butterflies. For that reason, Butterflies is seeing an adjustment which effectively works as a nerf to Fairytale.

  • ReworkedButterflies7 dmg12 dmg · 1.4s CD1.8s CD

The Vampire set generally has a healthy power-level (albeit a high use-rate), but Red Rose proved slightly too strong in high star-tiers.

  • NerfedRed Rose20/40/80/100 % max hp20/30/40/80% max hp

The Goblin pack was the least used pack, so some of the underperforming Goblin items are seeing a buff:

  • BuffedBomb Wagon2 Charges3 Charges
  • BuffedHeavy Bomb250 dmg300 dmg
  • BuffedHoning Steel3.4s CD3s CD
  • BuffedCannon3.5s CD3.4s CD · 60g55g25/33/50% bomb stat gain → 30/50/70% bomb stat gain.

Additional buffs for underperforming items:

  • BuffedGlacier35 dmg45 dmg · 40g35g
  • BuffedKingslayer3.7s CD3.6s CD
  • BuffedEmerald Sword20 dmg40 dmg
  • BuffedNightfall4.3s CD4.1s CD
  • BuffedHunter's Tome25g20g

Other

  • You can now select "Random Perk" even though you didn't unlock all perks. You only gain bonus rating if you actually unlocked all.
  • 3-Star Crook now has alternative name: Fluffeh's Crook.

Fixes

  • Fixed a bug where using Time Tonic would only count towards the "Growth" achievement when right-clicking the potion.
  • Unlocking Rare Find or Gambit (win while only buying rare/epic items) no longer cares if you buy potions or special items.

//Bocary

Comments
Sign in to join the discussion.
No comments yet
Be the first to weigh in.